| Trial ID: | L0326 |
| Source ID: | NCT02394145
|
| Associated Drug: |
Ticagrelor
|
| Title: |
Genotype and Platelet Reactivity in Patients on Hemodialysis
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Ticagrelor|DRUG: Clopidogrel
|
| Outcome Measures: |
Primary: The difference of antiplatelet effects according to genotype, The difference of P2Y12 reaction units (PRUs) according to genotype, 14 days after study drug treatment | Secondary: The difference of antiplatelet effects according to kidney function, The difference of P2Y12 reaction units (PRUs) according to kidney function, 14 days after study drug treatment
|
| Sponsor/Collaborators: |
Sponsor: Kyunghee University Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-09
|
| Completion Date: |
2015-08
|
| Results First Posted: |
|
| Last Update Posted: |
2015-03-20
|
| Locations: |
Kyung Hee University Hospital, Seoul, 130-872, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02394145
|
